Liver Tumor Promoting Effects of Febantel in a Two-stage Hepatocarcinogenesis Model of Rats Using D-galactosamine and Diethylnitrosamine
Autor: | Hiroshi Onodera, Masahiro Kikuchi, Kiyoshi Takegawa, Kazuo Yasuhara, Masao Hirose, Tsutomu Ichiki, Chikako Uneyama, Kunitoshi Mitsumori |
---|---|
Rok vydání: | 1999 |
Předmět: |
medicine.medical_specialty
Liver tumor Chemistry medicine.medical_treatment Promotion effect Intraperitoneal injection CYP1A2 F344 rats D galactosamine Toxicology Dose level Body weight medicine.disease digestive system diseases Pathology and Forensic Medicine Endocrinology Biochemistry Internal medicine medicine |
Zdroj: | Journal of Toxicologic Pathology. 12:113-117 |
ISSN: | 1881-915X 0914-9198 |
Popis: | To examine whether febantel has a tumor promoting activity, a total of 50 male F344 rats, divided into five groups each consisting of 10 rats, were initiated with a single intraperitoneal injection of 100 mg/kg of diethylnitrosamine (DEN). Starting 1 week later, Groups 1, 2, and 3 were fed diet containing 2,500,500, and 0 ppm febantel, respectively, for 7 weeks. D-galactosamine (DGA) of 300 mg/kg was administered intraperitoneally at Weeks 1 and 6 of febantel treatment. The remaining two groups (Groups 4 and 5) were fed diet containing 2,000 or 0 ppm febantel without DGA treatment for 7 weeks. Animals in the DEN/DGA + 2,500 ppm group showed a significant depression of body weight gain, as compared to the DEN/DGA + 0 ppm group. Significant increases in the absolute and relative liver weights were observed in the DEN/DGA + 2,500 ppm and DEN +2,000 ppm groups in comparison with the corresponding controls. Similar increases in the relative liver weights were also seen in the DEN/DGA + 500 ppm group. Histologically, centrilobular hepatocellular hypertrophy was observed in the DEN/DGA + 2,500 ppm and DEN +2,000 ppm groups. Significant induction of CYP1A1/2, 2B1/2 and 4A1/3 was observed in the DEN/DGA + 2,500 ppm and DEN +2,000 ppm groups, as compared to the corresponding control groups. Similar induction of CYP1A2 and 2B1 was observed in the DEN/DGA + 500 ppm group. Significant increases in GST-P positive cells and/or mini-foci in the liver were observed in the DEN/DGA + 2,500 ppm group. These results suggest that febantel exerts liver tumor promotion potential. Since no increases in GST-P positive cells and/or foci in the liver were observed at the dose level of DEN/DGA + 500 ppm febantel, this dose is considered to be a no effect level for this promotion effect. |
Databáze: | OpenAIRE |
Externí odkaz: |